DEVELOPING AND TESTING A STATED-PREFERENCE INSTRUMENT TO PRIORITIZE TREATMENT GOALS AMONG PATIENTS WITH RECENT ONSET SCHIZOPHRENIA

Author(s)

Beusterien K1, Chan E2, Such P3, Laird Ad2, Loze J2, Nylander A3, Robinson P2, Bridges JF4
1ORS Health, Washington, DC, USA, 2Otsuka Pharmaceutical Europe Ltd, Wexham, UK, 3H.Lundbeck AS, Copenhagen, Denmark, 4Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA

OBJECTIVES:  Younger patients with recent onset schizophrenia may value different treatment goals than patients with longer experience of the disease. We developed and tested a unique stated-preference instrument to prioritize multiple treatment goals among patients with recent onset schizophrenia. METHODS:  A best-worst scaling instrument (BWS) was developed based on a targeted review of the literature. Pre-testing interviews were conducted in the UK, Italy, and Germany among patients with recent onset schizophrenia (aged 18 to 35 who were diagnosed with schizophrenia within the past 5 years). The instrument involves rating the importance of 13 key treatment goals, which were identified based on a review of previous patient preference studies in schizophrenia. Patients completed the online survey in their native language, followed by a cognitive debriefing interview. The interviews were transcribed, and the data were analyzed by two researchers to assess patients’ understanding of the survey and the validity of the content. RESULTS:  Five pre-test interviews were conducted in each country. Across the 15 respondents the average age was 31.3

Conference/Value in Health Info

2016-10, ISPOR Europe 2016, Vienna, Austria

Value in Health, Vol. 19, No. 7 (November 2016)

Code

PMH34

Topic

Patient-Centered Research

Topic Subcategory

Stated Preference & Patient Satisfaction

Disease

Mental Health

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×